Skip to content

Immunic Inc (IMUX) Reports Year-End 2023 Financial Results

  • by
  • 1 min read

Strengthened Balance Sheet and Progress in Clinical Trials Highlighted

Join the conversation

Your email address will not be published. Required fields are marked *